Skip to main navigation menu Skip to main content Skip to site footer

Review article: Biomedical intelligence

Vol. 143 No. 1112 (2013)

Uptake of guidelines on prevention of mother-to-child transmission of HIV in rural Tanzania: time for change

  • Anna Gamell
  • Emili Letang
  • Boniface Jullu
  • Geoffrey Mwaigomole
  • Angelo Nyamtema
  • Christoph Hatz
  • Manuel Battegay
  • Marcel Tanner
DOI
https://doi.org/10.4414/smw.2013.13775
Cite this as:
Swiss Med Wkly. 2013;143:w13775
Published
10.03.2013

Summary

Guidelines on prevention of mother-to-child transmission (PMTCT) of human immunodeficiency virus (HIV) are inconsistently implemented in low-income countries. Strategies are needed to improve the uptake of these guidelines to prevent avoidable new HIV infections of infants. In 2010 the World Health Organisation presented its new PMTCT guidelines, offering two options for short courses of antiretroviral prophylaxis: Option A and Option B. Option A consists of antenatal prophylaxis with zidovudine followed by intrapartum and postpartum prophylaxis with single-dose nevirapine and zidovudine plus lamivudine. Option B recommends triple antiretroviral prophylaxis until after finishing breastfeeding. Tanzania has adopted Option A, and it is currently implementing it. A new option termed Option B+ has emerged recently, which recommends providing lifelong antiretroviral treatment to all HIV-positive pregnant women.

In this article, we discuss the likely impact of this last PMTCT strategy in rural Africa with an example of an observational cross-sectional analysis in a rural referral hospital in Tanzania aiming to assess the uptake of PMTCT recommendations. Gaps were identified at all steps of the PMTCT pathway.

Effective uptake of PMTCT guidelines has been shown to be extremely challenging in this setting. The continuously changing recommendations on PMTCT stress the need for a much simpler and effective approach. We argue in favour of implementing Option B+ in Tanzania. Financial challenges need to be faced, but Option B+ would help to overcome many barriers that prevent guidelines to be implemented in order to increase coverage and ultimately achieve the goal of ‘virtual elimination’ of mother-to-child transmission in sub-Saharan Africa.

References

  1. UNAIDS. Joint United Nations Program on HIV/AIDS (UNAIDS). Global Report: UNAIDS report on the global AIDS epidemic 2010. Geneva, UNAIDS, 2010. Available from: http://www.unaids.org/globalreport/documents/20101123_GlobalReport_full_en.pdf.
  2. De Cock KM, Fowler MG, Mercier E, de Vincenzi I, Saba J, Hoff E, et al. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA: the journal of the American Medical Association. 2000;283(9):1175–82. Epub 2000/03/07.
  3. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O’Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994;331(18):1173–80. Epub 1994/11/03.
  4. European Collaborative Study. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis. 2005;40(3):458–65.
  5. WHO. New guidance on prevention of mother-to-child transmission of HIV and infant feeding in the context of HIV. Geneva, World Health Organization, 2010. Available from: http://www.who.int/hiv/pub/mtct/PMTCTfactsheet.pdf.
  6. European AIDS Clinical Society Guidelines (2011). Available from: http://www.europeanaidsclinicalsociety.org/images/stories/EACS-Pdf/EACSGuidelines-v6.0-English.pdf.
  7. Nkonki LL, Doherty TM, Hill Z, Chopra M, Schaay N, Kendall C. Missed opportunities for participation in prevention of mother to child transmission programmes: simplicity of nevirapine does not necessarily lead to optimal uptake, a qualitative study. AIDS research and therapy. 2007;4:27. Epub 2007/11/24.
  8. WHO. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report 2010. Geneva, World Health Organization, 2010. Available from: http://www.who.int/hiv/pub/2010progressreport
  9. UNAIDS. Joint United Nations Program on HIV/AIDS (UNAIDS). AIDSinfo Country fact sheets. Geneva, UNAIDS. Available from: http://www.unaids.org/en/dataanalysis/tools/aidsinfo/countryfactsheets/.
  10. Barker PM, Mphatswe W, Rollins N. Antiretroviral drugs in the cupboard are not enough: the impact of health systems’ performance on mother-to-child transmission of HIV. Journal of acquired immune deficiency syndromes. 2011;56(2):e45–8. Epub 2010/11/19.
  11. Ciaranello AL, Perez F, Keatinge J, Park JE, Engelsmann B, Maruva M, et al. What will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysis. PLoS medicine. 2012;9(1):e1001156. Epub 2012/01/19.
  12. WHO. Programmatic Update. Use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. April 2012. Geneva, World Health Organization, 2012. Available from: www.who.int/hiv/PMTCT_update.pdf.
  13. Ciaranello AL, Perez F, Engelsmann B, Walensky RP, Mushavi A, Rusibamayila A, et al. Cost-effectiveness of World Health Organization 2010 Guidelines for Prevention of Mother-to-Child HIV Transmission in Zimbabwe. Clin Infect Dis. 2012. Epub 2012/12/04.
  14. Tanzanian national guidelines for the Prevention of Mother-To-Child Transmission of HIV. The United Republic of Tanzania, Ministry of Health and Social Welfare, 2007.
  15. Tanzanian national guidelines for comprehensive care of Prevention of Mother-To-Child Transmission of HIV services. United Republic of Tanzania, Ministry of Health and Social Welfare, June 2012.
  16. Stoeckle M, McHomvu R, Hatz C, Battegay M, Aris EA, Mshinda H, et al. Moving up from 3 by 5. The Lancet infectious diseases. 2006;6(8):460–1. Epub 2006/07/28.
  17. Pasquet A, Messou E, Gabillard D, Minga A, Depoulosky A, Deuffic-Burban S, et al. Impact of drug stock-outs on death and retention to care among HIV-infected patients on combination antiretroviral therapy in Abidjan, Cote d’Ivoire. PloS one. 2010;5(10):e13414. Epub 2010/10/27.
  18. Schouten EJ, Jahn A, Midiani D, Makombe SD, Mnthambala A, Chirwa Z, et al. Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach. Lancet. 2011;378(9787):282–4. Epub 2011/07/19.
  19. Moses SE, Tosswill J, Sudhanva M, Poulton M, Zuckerman M. HIV-1 seroconversion during pregnancy resulting in vertical transmission. Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology. 2008;41(2):152–3. Epub 2007/12/07.
  20. Garcia PM, Kalish LA, Pitt J, Minkoff H, Quinn TC, Burchett SK, et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med. 1999;341(6):394–402. Epub 1999/08/05.
  21. Kasenga F, Hurtig AK, Emmelin M. Home deliveries: implications for adherence to nevirapine in a PMTCT programme in rural Malawi. AIDS care. 2007;19(5):646–52. Epub 2007/05/17.
  22. Kirsten I, Sewangi J, Kunz A, Dugange F, Ziske J, Jordan-Harder B, et al. Adherence to combination prophylaxis for prevention of mother-to-child-transmission of HIV in Tanzania. PloS one. 2011;6(6):e21020. Epub 2011/06/23.
  23. Mirkuzie AH, Hinderaker SG, Morkve O. Promising outcomes of a national programme for the prevention of Mother-to-Child HIV transmission in Addis Ababa: a retrospective study. BMC health services research. 2010;10:267. Epub 2010/09/11.
  24. Geddes R, Giddy J, Butler LM, Van Wyk E, Crankshaw T, Esterhuizen TM, et al. Dual and triple therapy to prevent mother-to-child transmission of HIV in a resource-limited setting – lessons from a South African programme. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. 2011;101(9):651-4. Epub 2011/09/17.
  25. WHO, UNICEF, UNAIDS, UNFPA. HIV and infant feeding. Update. Based on the technical consultation held on behalf of the Inter-agency Task Team (IATT) on Prevention of HIV Infection in Pregnant Women, Mothers and their Infants; 2006 Oct 25–27. Available from: http://whqlibdoc.who.int/publications/2007/9789241595964_eng.pdf.
  26. Vaz MJ, Barros SM, Palacios R, Senise JF, Lunardi L, Amed AM, et al. HIV-infected pregnant women have greater adherence with antiretroviral drugs than non-pregnant women. International journal of STD & AIDS. 2007;18(1):28–32. Epub 2007/03/01.
  27. Braitstein P, Katshcke A, Shen C, Sang E, Nyandiko W, Ochieng VO, et al. Retention of HIV-infected and HIV-exposed children in a comprehensive HIV clinical care programme in Western Kenya. Tropical medicine & international health: TM & IH. 2010;15(7):833–41. Epub 2010/05/22.
  28. WHO. Global HIV/AIDS response: epidemic update and health sector progress towards Universal Acccess. Progress report 2011. Geneva, World Health Organization, 2011. Available from: http://whqlibdoc.who.int/publications/2011/9789241502986_eng.pdf.
  29. Cook RE, Ciampa PJ, Sidat M, Blevins M, Burlison J, Davidson MA, et al. Predictors of successful early infant diagnosis of HIV in a rural district hospital in Zambezia, Mozambique. Journal of acquired immune deficiency syndromes. 2011;56(4):e104–9. Epub 2011/01/27.
  30. Azcoaga-Lorenzo A, Ferreyra C, Alvarez A, Palma PP, Velilla E, del Amo J. Effectiveness of a PMTCT programme in rural Western Kenya. AIDS care. 2011;23(3):274–80. Epub 2011/02/25.
  31. Mirkuzie AH, Hinderaker SG, Sisay MM, Moland KM, Morkve O. Current status of medication adherence and infant follow up in the prevention of mother to child HIV transmission programme in Addis Ababa: a cohort study. Journal of the International AIDS Society. 2011;14:50. Epub 2011/10/25.
  32. Youngleson MS, Nkurunziza P, Jennings K, Arendse J, Mate KS, Barker P. Improving a mother to child HIV transmission programme through health system redesign: quality improvement, protocol adjustment and resource addition. PloS one. 2010;5(11):e13891. Epub 2010/11/19.
  33. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505. Epub 2011/07/20.
  34. Shelton JD. HIV/AIDS. ARVs as HIV prevention: a tough road to wide impact. Science. 2011;334(6063):1645–6. Epub 2011/12/24.

Most read articles by the same author(s)

1 2 3 > >>